In the News

1855 News Items found
Judith Nelson with a patient
In the Clinic
MSK’s Supportive Care Service aims to improve quality of life for all people with cancer.
Bob Fontaine (with daughter Mariah, mother Margaret, and wife Ann) credits Dr. Ariyan's trial with saving his life.
In the Clinic
Meet three people who were treated as part of a clinical trial for melanoma at Memorial Sloan Kettering.
Jedd Wolchok and Charlotte Ariyan in the lab
In the Clinic
A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.
3D illustration of a heart
Q&A
The American Heart Association recently issued a statement about the risk of cardiovascular disease for women with breast cancer.
Medical oncologist Jae Park
In the Clinic
The study represents 20 years of research at MSK.
A yellow molecular model of the androgen receptor on brown background
In the Clinic
Doctors are developing treatment strategies that target the androgen receptor, which is found in many triple-negative breast cancers.
MSK's Neil Iyengar will present at the American Association for Cancer Research special conference about the risk of invasive breast cancer. A new study found that the risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat. These findings suggest that having a normal BMI can provide false reassurance regarding the risk of breast cancer associated with body fat, and they also highlight the potential role of physical activity and exercise even in those who are at a normal weight. For expert interviews, please contact Nicole H. McNamara at [email protected].
abstract red and blue lines suggestive of metabolic pathways
In the Lab
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
Physician-scientist Ross Levine and research technician Aishwarya Krishnan speak in the lab
In the Clinic
MSK's new clinic will focus on clonal hematopoiesis, a condition related to aging that increases the risk of developing certain blood cancers.
Enlarged microscopic image of blue-green immune cells surrounding one blue cancer cell.
Q&A
Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.